DIUMIDE-K Tablets 40mg, 600m %v/v

Negara: Irlandia

Bahasa: Inggris

Sumber: HPRA (Health Products Regulatory Authority)

Bahan aktif:

FUROSEMIDE POTASSIUM CHLORIDE

Tersedia dari:

Napp Pharmaceuticals Limited

Dosis:

40mg, 600m %v/v

Bentuk farmasi:

Tablets

Tanggal Otorisasi:

1998-01-04

Karakteristik produk

PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Diumide-K Continus prolonged release, film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Furosemide 40 mg
Potassium Chloride 600 mg (prolonged release). 
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Prolonged release, film-coated tablets. 
Orange/white, film coated, bi-layered tablets with
the letters ‘DK’ on the orange coloured layer.
4 CLINICAL PARTICULARS 
4.1 THERAPEUTIC INDICATIONS
In the management of fluid retention in which
potassium supplementation is required in support of a diuretic 
administered daily, in mild to moderate hypertension, and in
oedema of various aetiologies.
4.2 POSOLOGY AND METHOD OF ADMINSTRATION
Route of Administration 
Oral. 
Adults only 
The usual dosage is one tablet daily.
4.3 CONTRAINDICATIONS
1.
Use of the combination in the presence of hyperkalaemia,
precoma associated with hepatic
             cirrhosis, or Addison’s disease. 
2.
Use in children. 
3.
Hypersensitivity to furosemide, potassium chloride or any
other constituent of the tablets. 
4.         Patients with rare hereditary
problems of galactose intolerance, the Lapp lactase deficiency or
             glucose-galactose malabsorption should
not take this medicine.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Issued 10/08/2005_
_CRN 2012558_
_page number: 1_
4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
1.
Patients who are being treated with this preparation
require regular supervision with monitoring of fluid and 
             electrolyte state to avoid
inadequate potassium supplementation
or excessive loss of fluid. 
2.
The dosage of potassium supplied with this regimen
is not adjusted to the requirements of any patients and
             the physician